IBSA USA
Adam Salloum is an experienced accounting professional currently serving as an Accounting Analyst at IBSA USA since April 2023. Prior to this role, Adam worked as an Accounts Receivable Analyst at Glenmark Pharmaceuticals, where responsibilities included preparing financial reports, resolving account discrepancies, managing a significant portfolio of receivables, and collecting revenue. Adam also gained experience as a Financial Planning Intern at Prudential Financial, supporting financial professionals and assisting with client account maintenance. Adam holds a Bachelor of Science degree in Finance from the University of Tampa, obtained in 2022.
This person is not in any teams
IBSA USA
IBSA USA is the subsidiary of IBSA Group, the largest privately owned pharmaceutical company in Switzerland. IBSA is committed to improving patient quality of life through research, innovation, and the development of effective drugs and cutting-edge technologies. IBSA USA markets two unique levothyroxine formulations in the U.S. for the treatment of hypothyroidism: Tirosint® (levothyroxine sodium) capsules and Tirosint®-SOL (levothyroxine sodium) oral solution. IBSA also markets Licart™ (diclofenac epolamine) topical system 1.3%, the only once-a-day topical nonsteroidal anti-inflammatory (NSAID) available in the U.S. to treat acute pain due to minor strains, sprains, and contusions. IBSA is focused on the health and well-being of patients and driven by the desire to bring therapeutic alternatives to as many people as possible. IBSA Group bases its philosophy on four sustainable pillars: Person, Innovation, Quality, and Responsibility. For more information about Tirosint, Tirosint-SOL, or Licart, including Full Prescribing Information, go to each brand’s respective website.